Buscar
Mostrando ítems 1-10 de 31
Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine
(Elsevier B.V., 2003-12-01)
The fucose mannose ligand (Leishmania donovani FML)-saponin vaccine has earlier shown its immunoprophylactic potential against visceral leishmaniasis in the CB hamster (87.7% of parasite load reduction), Balb/c (84.4%) and ...
Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine
(Elsevier B.V., 2003-12-01)
The fucose mannose ligand (Leishmania donovani FML)-saponin vaccine has earlier shown its immunoprophylactic potential against visceral leishmaniasis in the CB hamster (87.7% of parasite load reduction), Balb/c (84.4%) and ...
Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis
(Elsevier B.V., 2002-11-22)
The FML antigen of Leishmania donovani, in combination with either Riedel de Haen (R), QuilA, QS21 saponins, IL12 or BCG, was used in vaccination of an outbred murine model against visceral leishmaniasis (VL). Significant ...
Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasis
(Elsevier B.V., 2002-11-22)
The FML antigen of Leishmania donovani, in combination with either Riedel de Haen (R), QuilA, QS21 saponins, IL12 or BCG, was used in vaccination of an outbred murine model against visceral leishmaniasis (VL). Significant ...
Leishmune (R) vaccine blocks the transmission of canine visceral leishmaniasis - Absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs
(Elsevier B.V., 2005-09-23)
Leishmune (R) vaccine is the first licensed vaccine against canine visceral leishmaniasis. It contains the Fucose-Mannose-ligand (FML) antigen of Leishmania donovani. The potential Leishmune (R) vaccine effect on the ...
Leishmune (R) vaccine blocks the transmission of canine visceral leishmaniasis - Absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs
(Elsevier B.V., 2005-09-23)
Leishmune (R) vaccine is the first licensed vaccine against canine visceral leishmaniasis. It contains the Fucose-Mannose-ligand (FML) antigen of Leishmania donovani. The potential Leishmune (R) vaccine effect on the ...
FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine
(Taylor & Francis, 2019)
Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine
(Elsevier B.V., 2014)